{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Kim KN"],"funding":["Korean Foundation for Cancer Research","Ministry of Education, Science and Technology","National Research Foundation of Korea"],"pagination":["1392-1399"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6790863"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["51(4)"],"pubmed_abstract":["<h4>Purpose</h4>The association between tobacco smoking and thyroid cancer remains uncertain. We evaluated the associations of active and passive smokingwith the risk of papillary thyroid cancer (PTC), the most common type of thyroid cancer, and with the BRAFV600E mutation, the most common oncogenic mutation in PTC related to poor prognosis.<h4>Materials and methods</h4>We conducted this study with newly diagnosed PTC patients (n=2,142) and community controls (n=21,420) individually matched to cases for age and sex. Information on active and passive smoking and potential confounders were obtained from structured questionnaires, anthropometric measurements, and medical records. BRAFV600E mutation status was assessed in PTC patients. We evaluated the associations of active and passive smokin"],"journal":["Cancer research and treatment"],"pubmed_title":["Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study."],"pmcid":["PMC6790863"],"funding_grant_id":["CB-2011-03-01","2011-0001564"],"pubmed_authors":["Lee KE","Kim KN","Choi JY","Kang D","Park YJ","Kim K","Park DJ","Cho B","Park SK","Hwang Y"],"additional_accession":[]},"is_claimable":false,"name":"Active and Passive Smoking, BRAFV600E Mutation Status, and the Risk of Papillary Thyroid Cancer: A Large-Scale Case-Control and Case-Only Study.","description":"<h4>Purpose</h4>The association between tobacco smoking and thyroid cancer remains uncertain. We evaluated the associations of active and passive smokingwith the risk of papillary thyroid cancer (PTC), the most common type of thyroid cancer, and with the BRAFV600E mutation, the most common oncogenic mutation in PTC related to poor prognosis.<h4>Materials and methods</h4>We conducted this study with newly diagnosed PTC patients (n=2,142) and community controls (n=21,420) individually matched to cases for age and sex. Information on active and passive smoking and potential confounders were obtained from structured questionnaires, anthropometric measurements, and medical records. BRAFV600E mutation status was assessed in PTC patients. We evaluated the associations of active and passive smokin","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Oct","modification":"2025-04-07T12:53:17.195Z","creation":"2025-04-07T12:53:17.195Z"},"accession":"S-EPMC6790863","cross_references":{"pubmed":["30786705"],"doi":["10.4143/crt.2018.612"]}}